SCHEMBL22787266

SCHEMBL22787266

CC(C)NC(=O)CCC(C)(C)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.47
FAAH O00519 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
CHRM5 P08912 1/20 0.38
CHRM3 P20309 1/20 0.38
HPGD P15428 2/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 1/20 0.36
NLRP1 Q9C000 1/20 0.36
TSHR P16473 3/20 0.35
PIK3CD O00329 1/20 0.34
MAPT P10636 1/20 0.34
LMNA P02545 3/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
CYP3A4 P08684 1/20 0.33
NFKB1 P19838 1/20 0.33
ADRA1A P35348 1/20 0.33
RAB9A P51151 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16473888 0.83 MEN1 (0.50) MEN1FAAHMAPK1KMT2ACHRM5
SCHEMBL19200200 0.81 MEN1 (0.48) MEN1FAAHMAPK1KMT2ACHRM5
SCHEMBL18787676 0.81 LMNA (0.41) ALDH1A1PIK3CDLMNA
SCHEMBL28947382 0.81 MEN1 (0.48) MEN1FAAHMAPK1KMT2ACHRM5
SCHEMBL19199729 0.78 MEN1 (0.50) MEN1FAAHMAPK1KMT2ACHRM5
SCHEMBL13544834 0.78 MEN1 (0.46) MEN1FAAHMAPK1KMT2ACHRM5
SCHEMBL20805106 0.78 MEN1 (0.50) MEN1FAAHMAPK1KMT2ACHRM5
SCHEMBL13241282 0.78 MEN1 (0.46) MEN1FAAHMAPK1KMT2ACHRM5
SCHEMBL18786349 0.78 FAAH (0.44) FAAHKMT2AHPGDALDH1A1SMN1; SMN2
SCHEMBL5909062 0.77 MEN1 (0.62) MEN1FAAHMAPK1KMT2ACHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200392498-A1 POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS SOLSTICE BIOLOGICS LTD (IE) 2020-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200392498-A1 POLYNUCLEOTIDE CONSTRUCTS HAVING BIOREVERSIBLE AND NON-BIOREVERSIBLE GROUPS HNRNPC, RNASE1, NSUN3 MEN1 2230/4885FAAH 4672/4885MAPK1 4730/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.